Skip to main content

Table 2 Mean and median urine albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) by race

From: Asian Americans & chronic kidney disease in a nationally representative cohort

  

Race

Outcome

Statistic

Asians

White

ACR mg/g (A1, A2, A3)

Mean ± SE

38.4 ± 7.1

25.7 ± 2.6

[CKD Stage 1–5]

Median (Q1, Q3)

7.2 (4.8, 12.8)

6.8 (4.6, 12.1)

ACR ≥ 30 mg/g (A2)

Mean ± SE

311.4 ± 68.1

201.4 ± 27.0

[CKD Stage 3]

Median (Q1, Q3)

76.6 (39.8, 198.1)

57.4 (39.6, 120.8)

ACR > 300 mg/g (A3)

Mean ± SE

1255.7 ± 298

1225.1 ± 204

[CKD Stages 4–5]

Median (Q1, Q3)

628.2 (427.0, 1081.6)

657.1 (404.9, 1140.9)

eGFR ml/min/1.73 m2 (G1 to G5)

Mean ± SE

101.2 ± 0.5

90.3 ± 0.3

[CKD Stages 1–5]

Median (Q1,Q3)

103.3 (90.2, 115.5)

91.8 (76.8, 105.5)

eGFR < 60 ml/min/1.73 m2 (G3a-G5)

Mean ± SE

48.6 ± 1.63

47.7 ± 0.57

[CKD Stage 3 to 5]

Median (Q1, Q3)

51.8 (43.9, 57.5)

50.7 (41.9, 55.7)

eGFR < 45 ml/min/1.73 m2 (G3b-G5)

Mean ± SE

34.1 ± 2.8

33.5 ± 0.9

[CKD Stage 3 to 5]

Median (Q1, Q3)

37.1 (27.9, 42.6)

35.7 (30.6, 41.0)

  1. SE standard error; Q1 1st quartile, Q3 3rd quartile
  2. Note: UACR has a skewed distribution and therefore we would suggest using median (Q1, Q3), while eGFR is normally distributed and therefore would suggest using mean and standard error
  3. ACR ≥ 30 mg/g (A2) – Moderately increased; ACR > 300 mg/g (A3) – Severely increased; eGFR < 60 ml/min/1.73 m2 (G3a) – Mildly to moderately decreased; eGFR < 45 ml/min/1.73 m2 (G3b) – Moderately to severely decreased